Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pedro Aguiar Junior"'
Autor:
Pedro Aguiar Junior, Pedro De-Marchi, Rafael Paes, Isabella Favato, Gabriela Monte, Tatiane Montella, Filipe Visani, Nathalia Afonso, Izabella Negreiros, Rodrigo Dienstmann, Carlos Gil Ferreira
Publikováno v:
Brazilian Journal of Oncology, Vol 19 (2023)
INTRODUCTION: Immunotherapy led to increased survival in advanced non-small cell lung cancer; however, it has also increased treatment costs. In this study, real-world data was used to evaluate the average cost of treatment of patients with lung canc
Externí odkaz:
https://doaj.org/article/d58a627f4c00416da5abac6aa5924ee9
Publikováno v:
Brazilian Journal of Oncology, Vol 19 (2023)
Despite the absence of data regarding direct costs for healthcare, oncological patients from the Brazilian Unified Public Healthcare System often face significant financial burden due to out-of-pocket costs associated with their treatment. These c
Externí odkaz:
https://doaj.org/article/9f549749357d4e1a81c66ddb25cff415
Publikováno v:
International Brazilian Journal of Urology, Vol 42, Iss 1, Pp 29-36 (2016)
ABSTRACT Purpose Among renal malignancies, renal cell carcinoma (RCC) accounts for 85% of cases. Stage is a relevant prognostic factor; 5-year survival ranges from 81% to 8% according to the stage of disease. The treatment is based on surgery and mol
Externí odkaz:
https://doaj.org/article/5b6b3e40a09c4ff5878100ba86ea9f11
Autor:
Pedro Aguiar Júnior, Carmelia Maria Noia Barreto, Felipe Roitberg, Gilberto Lopes Júnior, Auro del Giglio
Publikováno v:
São Paulo Medical Journal, Vol 137, Iss 6, Pp 505-511 (2020)
ABSTRACT BACKGROUND: Lung cancer is the fourth most common cancer in Brazil. In the 2000s, better understanding of molecular pathways led to development of epidermal growth factor receptor (EGFR)-targeted treatments that have improved outcomes. Howev
Externí odkaz:
https://doaj.org/article/eae3dcd5e72f465bb0d717efb9e78f1a